Related Experiment Video
Updated: Aug 30, 2025

Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis
Published on: October 2, 2020
Hydrogen Sulfide-to-Thiosulfate Ratio Associated with Blood Pressure Abnormalities in Pediatric CKD
Chien-Ning Hsu1,2, Wei-Ling Chen3, Wei-Ting Liao3
1Department of Pharmacy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan, China.
Insights
Children with chronic kidney disease (CKD) have high cardiovascular disease (CVD) risk. The H2S-to-thiosulfate ratio, not individual levels, correlated with CVD risk markers like blood pressure in pediatric CKD patients.
Area of Science:
- Pediatric Nephrology
- Cardiovascular Disease Research
- Biochemistry
Background:
- Cardiovascular disease (CVD) is a major concern in children with chronic kidney disease (CKD), necessitating early risk identification and intervention.
- Hydrogen sulfide (H2S), a signaling molecule, and its metabolite thiosulfate are implicated in both CKD and CVD.
- The interplay between H2S, thiosulfate, and CVD risk markers in pediatric CKD is not well understood.
Purpose of the Study:
- To investigate the associations of circulating hydrogen sulfide (H2S), thiosulfate, and their ratio with cardiovascular disease (CVD) risk markers in children and adolescents with chronic kidney disease (CKD).
- To explore potential differences in these associations based on CKD stage and blood pressure abnormalities.
Main Methods:
- Cross-sectional study involving 56 children and adolescents (aged 6-18 years) with CKD stages G1-G4.
- 24-hour ambulatory blood pressure monitoring (ABPM) was used to assess blood pressure load.
- Measurements included circulating H2S, thiosulfate levels, carotid artery intima-media thickness (cIMT), and left ventricular (LV) mass.
Main Results:
- Two-thirds of pediatric CKD patients exhibited elevated blood pressure load on ABPM, even in early stages.
- Children with ABPM abnormalities showed a higher H2S-to-thiosulfate ratio.
- The H2S-to-thiosulfate ratio positively correlated with 24-hour systolic blood pressure (SBP), nighttime SBP, and cIMT. H2S was negatively associated with LV mass, and thiosulfate was positively associated with 24-hour diastolic blood pressure (DBP) after confounder adjustment.
Conclusions:
- Circulating H2S, thiosulfate, and their ratio exhibit differential associations with CVD risk markers in pediatric CKD.
- The H2S-to-thiosulfate ratio appears more strongly linked to hypertension and arterial stiffness than individual components.
- Further research is warranted to explore the therapeutic potential of modulating the H2S signaling pathway for CVD prevention in childhood CKD.
Abstract:
Identifying children with chronic kidney disease (CKD) at high risk of cardiovascular disease (CVD) and ensuring they receive appropriate treatment can prevent CVD events and mortality later in life. Hydrogen sulfide (H2S) is a gaseous signaling molecule participating in CVD and CKD. Thiosulfate is not only an oxidation product of H2S but is also a H2S donor. We examined whether H2S, thiosulfate, and their combined ratio have differential associations with CVD risk markers in 56 children and adolescents aged 6-18 years with CKD stages G1-G4. Up to two-thirds of CKD children showed higher BP load on 24 h ambulatory blood pressure monitoring (ABPM), even in the early stage. CKD children with ABPM abnormalities had a higher H2S-to-thiosulfate ratio, while H2S-related parameters were not affected by the severity of CKD. The H2S-to-thiosulfate ratio was positively correlated with 24 h systolic BP (SBP), nighttime SBP, and carotid artery intima-media thickness (cIMT). After adjusting for confounders, H2S was negatively associated with LV mass, thiosulfate was positively associated with 24-DBP, and the H2S-to-thiosulfate ratio was positively correlated with nighttime SBP and cIMT. Our data demonstrate differential associations in circulating H2S, thiosulfate, and their combined ratio with CVD risk in childhood CKD. Further studies are required to determine whether targeting the H2S signaling pathway can develop novel therapeutic strategies against CVD in this high-risk population.
More Related Videos
Related Concept Videos
Serum Studies: Renal Function Tests
Hemodialysis II: Procedure and Complications
Henderson-Hasselbalch Equation
Antihypertensive Drugs: Thiazide-Class Diuretics
Heart Failure VI: Adjunct Therapies
Antihypertensive Drugs: Potassium-Sparing Diuretics

